Nano-Therapeutics for the Lung: State-of-the-Art and Future Perspectives

Author(s): Roshni Iyer, Connie C. W. Hsia, Kytai T. Nguyen

Journal Name: Current Pharmaceutical Design

Volume 21 , Issue 36 , 2015

Become EABM
Become Reviewer


Inhalation of aerosolized compounds is a popular, non-invasive route for the targeted delivery of therapeutic molecules to the lung. Various types of nanoparticles have been used as carriers to facilitate drug uptake and intracellular action in order to treat lung diseases and/or to facilitate lung repair and growth. These include polymeric nanoparticles, liposomes, and dendrimers, among many others. In addition, nanoparticles are sometimes used in combination with small molecules, cytokines, growth factors, and/or pluripotent stem cells. Here we review the rationale and state-of-the-art nanotechnology for pulmonary drug delivery, with particular attention to new technological developments and approaches as well as the challenges associated with them, the emerging advances, and opportunities for future development in this field.

Keywords: Nanoparticles, pulmonary delivery, inhalation, aerosolization, lung disease, lung repair, growth factors, stem cells.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 02 November, 2015
Page: [5233 - 5244]
Pages: 12
DOI: 10.2174/1381612821666150923095742
Price: $65

Article Metrics

PDF: 37
PRC: 1